請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17281
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 邱麗珠(Lih-Chu Chiou) | |
dc.contributor.author | Yu-Hsiang Liao | en |
dc.contributor.author | 廖御翔 | zh_TW |
dc.date.accessioned | 2021-06-08T00:04:44Z | - |
dc.date.copyright | 2013-09-24 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-14 | |
dc.identifier.citation | 'Schizophrenia' Concise Medical Dictionary (2010). O. U. Press. Maastricht University Library.
Abdalla, S., M. Abu-Zarga, F. Afifi, S. Al-Khalil and S. Sabri (1988). 'Effects of hispidulin, a flavone isolated from Inula viscosa, on isolated guinea-pig smooth muscle.' Gen Pharmacol 19(4): 559-563. Abelson, J. F., K. Y. Kwan, B. J. O'Roak, D. Y. Baek, A. A. Stillman, T. M. Morgan, C. A. Mathews, D. L. Pauls, M. R. Rasin, M. Gunel, N. R. Davis, A. G. Ercan-Sencicek, D. H. Guez, J. A. Spertus, J. F. Leckman, L. S. t. Dure, R. Kurlan, H. S. Singer, D. L. Gilbert, A. Farhi, A. Louvi, R. P. Lifton, N. Sestan and M. W. State (2005). 'Sequence variants in SLITRK1 are associated with Tourette's syndrome.' Science 310(5746): 317-320. Aherne, S. A. and N. M. O'Brien (2002). 'Dietary flavonols: chemistry, food content, and metabolism.' Nutrition 18(1): 75-81. Aizenman, C. D., P. B. Manis and D. J. Linden (1998). 'Polarity of long-term synaptic gain change is related to postsynaptic spike firing at a cerebellar inhibitory synapse.' Neuron 21(4): 827-835. Akbarian, S., M. G. Ruehl, E. Bliven, L. A. Luiz, A. C. Peranelli, S. P. Baker, R. C. Roberts, W. E. Bunney, Jr., R. C. Conley, E. G. Jones, C. A. Tamminga and Y. Guo (2005). 'Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia.' Arch Gen Psychiatry 62(8): 829-840. Albin, R. L. and J. W. Mink (2006). 'Recent advances in Tourette syndrome research.' Trends Neurosci 29(3): 175-182. Albus, K. (1972). 'Method for application of drugs into separated parts of the cerebroventricular system.' Physiol Behav 8(3): 569-571. Alexander, G. E. and M. D. Crutcher (1990). 'Functional architecture of basal ganglia circuits: neural substrates of parallel processing.' Trends Neurosci 13(7): 266-271. Alexander, G. E., M. R. DeLong and P. L. Strick (1986). 'Parallel organization of functionally segregated circuits linking basal ganglia and cortex.' Annu Rev Neurosci 9: 357-381. Anchisi, D., B. Scelfo and F. Tempia (2001). 'Postsynaptic currents in deep cerebellar nuclei.' J Neurophysiol 85(1): 323-331. Andreasen, N. C. (2000). 'Schizophrenia: the fundamental questions.' Brain Res Brain Res Rev 31(2-3): 106-112. Asolker LV, K. K., Chakra OJ. (1992). 'Second Supplement to Glossary of Indian Medicinal Plants With Active Principles. .' New Delhi: Pub. & Inf. Div. (CSIR);: :414. Atack, J. R. (2003). 'Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.' Curr Drug Targets CNS Neurol Disord 2(4): 213-232. Barnard, E. A., P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson and S. Z. Langer (1998). 'International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.' Pharmacol Rev 50(2): 291-313. Baym, C. L., B. A. Corbett, S. B. Wright and S. A. Bunge (2008). 'Neural correlates of tic severity and cognitive control in children with Tourette syndrome.' Brain 131(Pt 1): 165-179. Belelli, D., M. B. Herd, E. A. Mitchell, D. R. Peden, A. W. Vardy, L. Gentet and J. J. Lambert (2006). 'Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance.' Neuroscience 138(3): 821-829. Belelli, D., D. R. Peden, T. W. Rosahl, K. A. Wafford and J. J. Lambert (2005). 'Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics.' J Neurosci 25(50): 11513-11520. Biswal, B., J. L. Ulmer, R. L. Krippendorf, H. H. Harsch, D. L. Daniels, J. S. Hyde and V. M. Haughton (1998). 'Abnormal cerebral activation associated with a motor task in Tourette syndrome.' AJNR Am J Neuroradiol 19(8): 1509-1512. Bohlhalter, S., A. Goldfine, S. Matteson, G. Garraux, T. Hanakawa, K. Kansaku, R. Wurzman and M. Hallett (2006). 'Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study.' Brain 129(Pt 8): 2029-2037. Bolam, J. P., J. J. Hanley, P. A. Booth and M. D. Bevan (2000). 'Synaptic organisation of the basal ganglia.' J Anat 196 ( Pt 4): 527-542. Bostan, A. C., R. P. Dum and P. L. Strick (2010). 'The basal ganglia communicate with the cerebellum.' Proc Natl Acad Sci U S A 107(18): 8452-8456. Bostan, A. C. and P. L. Strick (2010). 'The cerebellum and basal ganglia are interconnected.' Neuropsychol Rev 20(3): 261-270. Bourdillat, B., D. Delautier, C. Labat, J. Benveniste, P. Potier and C. Brink (1988). 'Mechanism of action of hispidulin, a natural flavone, on human platelets.' Prog Clin Biol Res 280: 211-214. Braff, D., C. Stone, E. Callaway, M. Geyer, I. Glick and L. Bali (1978). 'Prestimulus effects on human startle reflex in normals and schizophrenics.' Psychophysiology 15(4): 339-343. Braun, A. R., B. Stoetter, C. Randolph, J. K. Hsiao, K. Vladar, J. Gernert, R. E. Carson, P. Herscovitch and T. N. Chase (1993). 'The functional neuroanatomy of Tourette's syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls.' Neuropsychopharmacology 9(4): 277-291. Brunig, I., E. Scotti, C. Sidler and J. M. Fritschy (2002). 'Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro.' J Comp Neurol 443(1): 43-55. Buckley, P. F. and S. M. Stahl (2007). 'Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?' Acta Psychiatr Scand 115(2): 93-100. Bullock, W. M., K. Cardon, J. Bustillo, R. C. Roberts and N. I. Perrone-Bizzozero (2008). 'Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.' Am J Psychiatry 165(12): 1594-1603. Castellanos, F. X., E. J. Fine, D. Kaysen, W. L. Marsh, J. L. Rapoport and M. Hallett (1996). 'Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.' Biological psychiatry 39(1): 33-41. Centonze, D., S. Rossi, P. De Bartolo, V. De Chiara, F. Foti, A. Musella, G. Mataluni, S. Rossi, G. Bernardi, G. Koch and L. Petrosini (2008). 'Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage.' Eur J Neurosci 27(8): 2188-2196. Chase, T. N., V. Geoffrey, M. Gillespie and G. H. Burrows (1986). 'Structural and functional studies of Gilles de la Tourette syndrome.' Rev Neurol (Paris) 142(11): 851-855. Chen, H.-L. (2009). The Clerodendrum inerme extracts inhibited the hyperlocomotor activity and impairment of prepulse inhibition induced by methamphetamine in mice., NTU. Chen, H. L., H. J. Lee, W. J. Huang, J. F. Chou, P. C. Fan, J. C. Du, Y. L. Ku and L. C. Chiou (2012). 'Clerodendrum inerme Leaf Extract Alleviates Animal Behaviors, Hyperlocomotion, and Prepulse Inhibition Disruptions, Mimicking Tourette Syndrome and Schizophrenia.' Evid Based Complement Alternat Med 2012: 284301. Chiou, L. C. L., H.J.; Chen, H. L.; Chou, J.F.; Y. Matsumoto; Huang, W.J.; M. Akihiro, Y. Aoyama, T. Mamiya, M. Hiramatsu, T. Nabeshima (2013). KLP-1 rescued prepulse inhibition disruptions and social withdrawal in animal models mimicking schizophrenia: A potential antipsychotic. WCFSBP Chou, J.-F. (2010). KLP-1 modulates α6-containing GABAAR-mediated tonic inhibition in cerebellar slices and reinstates ketamine-, MK-801- and methamphetamine-induced disruption of prepulse inhibition, NTU. Chulasiri, M., N. Bunyapraphatsara and P. Moongkarndi (1992). 'Mutagenicity and antimutagenicity of hispidulin and hortensin, the flavonoids from Millingtonia hortensis L.' Environ Mol Mutagen 20(4): 307-312. Clavin, M., S. Gorzalczany, A. Macho, E. Munoz, G. Ferraro, C. Acevedo and V. Martino (2007). 'Anti-inflammatory activity of flavonoids from Eupatorium arnottianum.' J Ethnopharmacol 112(3): 585-589. Coffey, B. J. and K. S. Park (1997). 'Behavioral and emotional aspects of Tourette syndrome.' Neurol Clin 15(2): 277-289. Cohen, D. J., B. A. Shaywitz, B. Caparulo, J. G. Young and M. B. Bowers, Jr. (1978). 'Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.' Arch Gen Psychiatry 35(2): 245-250. Collinson, N., J. R. Atack, P. Laughton, G. R. Dawson and D. N. Stephens (2006). 'An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze.' Psychopharmacology (Berl) 188(4): 619-628. Costa, E., E. Dong, D. R. Grayson, A. Guidotti, W. Ruzicka and M. Veldic (2007). 'Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability.' Epigenetics 2(1): 29-36. Csupor, D., U. Widowitz, G. Blazso, E. Laczko-Zold, J. S. Tatsimo, A. Balogh, K. Boros, B. Danko, R. Bauer and J. Hohmann (2013). 'Anti-inflammatory activities of eleven Centaurea species occurring in the Carpathian Basin.' Phytother Res 27(4): 540-544. D'Angelo, E. and S. Casali (2012). 'Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition.' Front Neural Circuits 6: 116. Dabaghi-Barbosa, P., A. Mariante Rocha, A. Franco da Cruz Lima, B. Heleno de Oliveira, M. Benigna Martinelli de Oliveira, E. Gunilla Skare Carnieri, S. M. Cadena and M. Eliane Merlin Rocha (2005). 'Hispidulin: antioxidant properties and effect on mitochondrial energy metabolism.' Free Radic Res 39(12): 1305-1315. Daskalakis, Z. J., G. O. Paradiso, B. K. Christensen, P. B. Fitzgerald, C. Gunraj and R. Chen (2004). 'Exploring the connectivity between the cerebellum and motor cortex in humans.' J Physiol 557(Pt 2): 689-700. de Gelder, B., J. Vroomen, S. J. de Jong, E. D. Masthoff, F. J. Trompenaars and P. Hodiamont (2005). 'Multisensory integration of emotional faces and voices in schizophrenics.' Schizophr Res 72(2-3): 195-203. Delis, F., A. Mitsacos and P. Giompres (2004). 'Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice.' Neuroscience 125(1): 255-268. Delis, F., A. Mitsacos and P. Giompres (2013). 'Lesion of the cerebellar paravermis increases dopamine D1 receptor levels in the contralateral striatum.' J Chem Neuroanat 47: 35-41. Dempsey, C. W. and D. E. Richardson (1987). 'Paleocerebellar stimulation induces in vivo release of endogenously synthesized [3H]dopamine and [3H]norepinephrine from rat caudal dorsomedial nucleus accumbens.' Neuroscience 21(2): 565-571. Derry, J. M., S. M. Dunn and M. Davies (2004). 'Identification of a residue in the gamma-aminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding.' J Neurochem 88(6): 1431-1438. Draganski, B., F. Kherif, S. Kloppel, P. A. Cook, D. C. Alexander, G. J. Parker, R. Deichmann, J. Ashburner and R. S. Frackowiak (2008). 'Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia.' J Neurosci 28(28): 7143-7152. Eccles, J. C. (1967). 'Circuits in the cerebellar control of movement.' Proc Natl Acad Sci U S A 58(1): 336-343. Fan, P. C., W. J. Huang and L. C. Chiou (2009). 'Intractable chronic motor tics dramatically respond to Clerodendrum inerme (L) Gaertn.' J Child Neurol 24(7): 887-890. Farrar, S. J., P. J. Whiting, T. P. Bonnert and R. M. McKernan (1999). 'Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer.' J Biol Chem 274(15): 10100-10104. Fernagut, P. O., S. Chalon, E. Diguet, D. Guilloteau, F. Tison and M. Jaber (2003). 'Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.' Neuroscience 116(4): 1123-1130. Ferrandiz, M. L., G. Bustos, M. Paya, R. Gunasegaran and M. J. Alcaraz (1994). 'Hispidulin protection against hepatotoxicity induced by bromobenzene in mice.' Life Sci 55(8): PL145-150. Fodor, L., T. Biro and G. Maksay (2005). 'Nanomolar allopregnanolone potentiates rat cerebellar GABAA receptors.' Neurosci Lett 383(1-2): 127-130. Fowler, S. C., T. J. Zarcone, E. Vorontsova and R. Chen (2002). 'Motor and associative deficits in D2 dopamine receptor knockout mice.' Int J Dev Neurosci 20(3-5): 309-321. Fritschy, J. M., J. Paysan, A. Enna and H. Mohler (1994). 'Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study.' J Neurosci 14(9): 5302-5324. Gauck, V. and D. Jaeger (2000). 'The control of rate and timing of spikes in the deep cerebellar nuclei by inhibition.' J Neurosci 20(8): 3006-3016. Geyer, M. A., K. Krebs-Thomson, D. L. Braff and N. R. Swerdlow (2001). 'Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.' Psychopharmacology (Berl) 156(2-3): 117-154. Goldman, L. S., M. Genel, R. J. Bezman and P. J. Slanetz (1998). 'Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.' JAMA 279(14): 1100-1107. Gonzales, R. A., M. O. Job and W. M. Doyon (2004). 'The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement.' Pharmacol Ther 103(2): 121-146. Gopal, N. and S. Sengottuvelu (2008). 'Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats.' Fitoterapia 79(1): 24-26. Graybiel, A. M. (2005). 'The basal ganglia: learning new tricks and loving it.' Curr Opin Neurobiol 15(6): 638-644. Griebel, G., D. J. Sanger and G. Perrault (1996). 'Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of 'state' and 'trait' anxiety.' Neuropharmacology 35(8): 1081-1091. Haber, S. N. (2003). 'The primate basal ganglia: parallel and integrative networks.' J Chem Neuroanat 26(4): 317-330. Haber, S. N., K. S. Kim, P. Mailly and R. Calzavara (2006). 'Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning.' J Neurosci 26(32): 8368-8376. Hadingham, K. L., E. M. Garrett, K. A. Wafford, C. Bain, R. P. Heavens, D. J. Sirinathsinghji and P. J. Whiting (1996). 'Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors.' Mol Pharmacol 49(2): 253-259. Hadingham, K. L., K. A. Wafford, S. A. Thompson, K. J. Palmer and P. J. Whiting (1995). 'Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.' Eur J Pharmacol 291(3): 301-309. Hamann, M., D. J. Rossi and D. Attwell (2002). 'Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex.' Neuron 33(4): 625-633. Harborne, J. B. a. B., H. (1999). 'The handbook of natural flavonoids.' John Wiley & Sons, chichester: Vol. 1 and 2. Harvey, P. D., D. Koren, A. Reichenberg and C. R. Bowie (2006). 'Negative symptoms and cognitive deficits: what is the nature of their relationship?' Schizophr Bull 32(2): 250-258. Hazekamp, A., R. Verpoorte and A. Panthong (2001). 'Isolation of a bronchodilator flavonoid from the Thai medicinal plant Clerodendrum petasites.' J Ethnopharmacol 78(1): 45-49. He, L., Y. Wu, L. Lin, J. Wang, Y. Wu, Y. Chen, Z. Yi, M. Liu and X. Pang (2011). 'Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.' Cancer Sci 102(1): 219-225. Heim, K. E., A. R. Tagliaferro and D. J. Bobilya (2002). 'Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.' J Nutr Biochem 13(10): 572-584. Ho, J. C. and C. M. Chen (2002). 'Flavonoids from the aquatic plant Eriocaulon buergerianum.' Phytochemistry 61(4): 405-408. Hoenig, K., A. Hochrein, B. B. Quednow, W. Maier and M. Wagner (2005). 'Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder.' Biological psychiatry 57(10): 1153-1158. Hoppenbrouwers, S. S., D. J. Schutter, P. B. Fitzgerald, R. Chen and Z. J. Daskalakis (2008). 'The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: a review.' Brain Res Rev 59(1): 185-200. Horan, P., B. R. de Costa, K. C. Rice and F. Porreca (1991). 'Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.' J Pharmacol Exp Ther 257(3): 1154-1161. Horie T, O. Y., Shibata K, et al. (1998). '13C NMR spectral assignment of the A-ring of polyoxygenated flavones. .' Phytochem 47 (45): 865-874. Hoshi, E., L. Tremblay, J. Feger, P. L. Carras and P. L. Strick (2005). 'The cerebellum communicates with the basal ganglia.' Nat Neurosci 8(11): 1491-1493. Ichinohe, N., F. Mori and K. Shoumura (2000). 'A di-synaptic projection from the lateral cerebellar nucleus to the laterodorsal part of the striatum via the central lateral nucleus of the thalamus in the rat.' Brain Res 880(1-2): 191-197. Ihara, M., C. Ishida, H. Okuda, Y. Ozoe and K. Matsuda (2005). 'Differential blocking actions of 4'-ethynyl-4-n-propylbicycloorthobenzoate (EBOB) and gamma-hexachlorocyclohexane (gamma-HCH) on gamma-aminobutyric acid- and glutamate-induced responses of American cockroach neurons.' Invert Neurosci 5(3-4): 157-164. Ito, M. (2008). 'Control of mental activities by internal models in the cerebellum.' Nat Rev Neurosci 9(4): 304-313. Jia, F., L. Pignataro and N. L. Harrison (2007). 'GABAA receptors in the thalamus: alpha4 subunit expression and alcohol sensitivity.' Alcohol 41(3): 177-185. Jia, F., M. Yue, D. Chandra, G. E. Homanics, P. A. Goldstein and N. L. Harrison (2008). 'Isoflurane is a potent modulator of extrasynaptic GABA(A) receptors in the thalamus.' J Pharmacol Exp Ther 324(3): 1127-1135. Joel, D. and I. Weiner (1994). 'The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated.' Neuroscience 63(2): 363-379. Kaenmaki, M., A. Tammimaki, T. Myohanen, K. Pakarinen, C. Amberg, M. Karayiorgou, J. A. Gogos and P. T. Mannisto (2010). 'Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.' J Neurochem 114(6): 1745-1755. Kataoka, Y., P. S. Kalanithi, H. Grantz, M. L. Schwartz, C. Saper, J. F. Leckman and F. M. Vaccarino (2010). 'Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.' J Comp Neurol 518(3): 277-291. Kavvadias, D., V. Monschein, P. Sand, P. Riederer and P. Schreier (2003). 'Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor.' Planta Med 69(2): 113-117. Kavvadias, D., P. Sand, K. A. Youdim, M. Z. Qaiser, C. Rice-Evans, R. Baur, E. Sigel, W. D. Rausch, P. Riederer and P. Schreier (2004). 'The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects.' Br J Pharmacol 142(5): 811-820. Kelly, J. S., K. Krnjevic, M. E. Morris and G. K. Yim (1969). 'Anionic permeability of cortical neurones.' Exp Brain Res 7(1): 11-31. Kent, K., Q. Deng and T. H. McNeill (2013). 'Unilateral skill acquisition induces bilateral NMDA receptor subunit composition shifts in the rat sensorimotor striatum.' Brain Res 1517: 77-86. Kerbeshian, J., C. Z. Peng and L. Burd (2009). 'Tourette syndrome and comorbid early-onset schizophrenia.' J Psychosom Res 67(6): 515-523. Knoflach, F., D. Benke, Y. Wang, L. Scheurer, H. Luddens, B. J. Hamilton, D. B. Carter, H. Mohler and J. A. Benson (1996). 'Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.' Mol Pharmacol 50(5): 1253-1261. Korpi, E. R., G. Grunder and H. Luddens (2002). 'Drug interactions at GABA(A) receptors.' Prog Neurobiol 67(2): 113-159. Korpi, E. R., T. Kuner, P. H. Seeburg and H. Luddens (1995). 'Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor.' Mol Pharmacol 47(2): 283-289. Kurlan, R., V. Eapen, J. Stern, M. P. McDermott and M. M. Robertson (1994). 'Bilineal transmission in Tourette's syndrome families.' Neurology 44(12): 2336-2342. Lager, E., J. Nilsson, E. Ostergaard Nielsen, M. Nielsen, T. Liljefors and O. Sterner (2008). 'Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABA(A) receptors.' Bioorg Med Chem 16(14): 6936-6948. Laurie, D. J., W. Wisden and P. H. Seeburg (1992). 'The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development.' J Neurosci 12(11): 4151-4172. Le Marchand, L. (2002). 'Cancer preventive effects of flavonoids--a review.' Biomed Pharmacother 56(6): 296-301. Leckman, J. F., D. E. Walker and D. J. Cohen (1993). 'Premonitory urges in Tourette's syndrome.' Am J Psychiatry 150(1): 98-102. Lee, H. J. C., L. C.; Huang, W. J. unpublished observation. Lerner, A., A. Bagic, E. A. Boudreau, T. Hanakawa, F. Pagan, Z. Mari, W. Bara-Jimenez, M. Aksu, G. Garraux, J. M. Simmons, S. Sato, D. L. Murphy and M. Hallett (2007). 'Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome.' Neurology 68(23): 1979-1987. Lerner, A., A. Bagic, J. M. Simmons, Z. Mari, O. Bonne, B. Xu, D. Kazuba, P. Herscovitch, R. E. Carson, D. L. Murphy, W. C. Drevets and M. Hallett (2012). 'Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome.' Brain 135(Pt 6): 1926-1936. Lewis, D. A., R. Y. Cho, C. S. Carter, K. Eklund, S. Forster, M. A. Kelly and D. Montrose (2008). 'Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.' Am J Psychiatry 165(12): 1585-1593. Lin, Y. C., C. M. Hung, J. C. Tsai, J. C. Lee, Y. L. Chen, C. W. Wei, J. Y. Kao and T. D. Way (2010). 'Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK).' J Agric Food Chem 58(17): 9511-9517. Lombroso, P. J., G. Mack, L. Scahill, R. A. King and J. F. Leckman (1991). 'Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: a family study.' Neurology 41(12): 1984-1987. Luk, K. C., L. Stern, M. Weigele, R. A. O'Brien and N. Spirt (1983). 'Isolation and identification of 'diazepam-like' compounds from bovine urine.' J Nat Prod 46(6): 852-861. Mandrioli, R., L. Mercolini and M. A. Raggi (2008). 'Benzodiazepine metabolism: an analytical perspective.' Curr Drug Metab 9(8): 827-844. Manto, M. (2008). 'The cerebellum, cerebellar disorders, and cerebellar research--two centuries of discoveries.' Cerebellum 7(4): 505-516. Manto, M. and D. Haines (2012). 'Cerebellar research: two centuries of discoveries.' Cerebellum 11(2): 446-448. Marder, C. W. a. M. (2012). 'Flavonoids as GABAA receptor ligands: the whole story?' Journal of Experimental Pharmacology: 15. Marr, D. (1969). 'A theory of cerebellar cortex.' J Physiol 202(2): 437-470. McCairn, K. W., A. Iriki and M. Isoda (2013). 'Global dysrhythmia of cerebro-basal ganglia-cerebellar networks underlies motor tics following striatal disinhibition.' J Neurosci 33(2): 697-708. McDougle, C. J., W. K. Goodman and L. H. Price (1994). 'Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.' J Clin Psychiatry 55 Suppl: 24-31. Medina, J. H., H. Viola, C. Wolfman, M. Marder, C. Wasowski, D. Calvo and A. C. Paladini (1997). 'Overview--flavonoids: a new family of benzodiazepine receptor ligands.' Neurochem Res 22(4): 419-425. Middleton, F. A. and P. L. Strick (2000). 'Basal ganglia and cerebellar loops: motor and cognitive circuits.' Brain Res Brain Res Rev 31(2-3): 236-250. Mink, J. W. (1996). 'The basal ganglia: focused selection and inhibition of competing motor programs.' Prog Neurobiol 50(4): 381-425. Mitchell, S. J. and R. A. Silver (2003). 'Shunting inhibition modulates neuronal gain during synaptic excitation.' Neuron 38(3): 433-445. Mitoma, H. and S. Konishi (1999). 'Monoaminergic long-term facilitation of GABA-mediated inhibitory transmission at cerebellar synapses.' Neuroscience 88(3): 871-883. Mogenson, G. J., M. Takigawa, A. Robertson and M. Wu (1979). 'Self-stimulation of the nucleus accumbens and ventral tegmental area of Tsai attenuated by microinjections of spiroperidol into the nucleus accumbens.' Brain Res 171(2): 247-259. Mohler, H. (2006). 'GABA(A) receptor diversity and pharmacology.' Cell Tissue Res 326(2): 505-516. Moufid, A. and M. Eddouks (2012). 'Artemisia herba alba: a popular plant with potential medicinal properties.' Pak J Biol Sci 15(24): 1152-1159. Mouginot, D. and B. H. Gahwiler (1995). 'Characterization of synaptic connections between cortex and deep nuclei of the rat cerebellum in vitro.' Neuroscience 64(3): 699-712. Mukherjee, P. K. and A. Wahile (2006). 'Integrated approaches towards drug development from Ayurveda and other Indian system of medicines.' J Ethnopharmacol 103(1): 25-35. Nicola, S. M. (2007). 'The nucleus accumbens as part of a basal ganglia action selection circuit.' Psychopharmacology (Berl) 191(3): 521-550. Nieoullon, A., A. Cheramy and J. Glowinski (1978). 'Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.' Brain Res 148(1): 143-152. Nieoullon, A. and N. Dusticier (1980). 'Changes in dopamine release in caudate nuclei and substantia nigrae after electrical stimulation of the posterior interposate nucleus of cat cerebellum.' Neurosci Lett 17(1-2): 167-172. Nomura, Y. and M. Segawa (2003). 'Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis.' Brain Dev 25 Suppl 1: S37-42. Nusser, Z. and I. Mody (2002). 'Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells.' J Neurophysiol 87(5): 2624-2628. Nusser, Z., W. Sieghart and P. Somogyi (1998). 'Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells.' J Neurosci 18(5): 1693-1703. O'Leary, D. S., M. Flaum, M. L. Kesler, L. A. Flashman, S. Arndt and N. C. Andreasen (2000). 'Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.' J Neuropsychiatry Clin Neurosci 12(1): 4-15. Ornitz, E. M., G. L. Hanna and J. de Traversay (1992). 'Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis.' Psychophysiology 29(4): 437-451. Orth, M., B. Amann, M. M. Robertson and J. C. Rothwell (2005). 'Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine.' Brain 128(Pt 6): 1292-1300. Panel (10/91) 'comment.' Park, W. K., D. Jeong, C. W. Yun, S. Lee, H. Cho, G. D. Kim, H. Y. Koh, A. N. Pae, Y. S. Cho, K. I. Choi, J. Y. Jung, S. H. Jung and J. Y. Kong (2003). 'Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.' Pharmacol Res 48(6): 615-622. Paxions, G. (2001). 'the mouse brain in stereotaxic coordinate.' Peedicayil, J. (2009). 'The role of epigenetics in altered gene expression involved in GABAergic transmission in the cerebellum of schizophrenia patients.' Am J Psychiatry 166(4): 493; author reply 493-494. Percheron, G., C. Francois, B. Talbi, J. Yelnik and G. Fenelon (1996). 'The primate motor thalamus.' Brain Res Brain Res Rev 22(2): 93-181. Perciavalle, V., S. Berretta and R. Raffaele (1989). 'Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat.' Neuroscience 29(1): 109-119. Peterson, B. S., P. Skudlarski, A. W. Anderson, H. Zhang, J. C. Gatenby, C. M. Lacadie, J. F. Leckman and J. C. Gore (1998). 'A functional magnetic resonance imaging study of tic suppression in Tourette syndrome.' Arch Gen Psychiatry 55(4): 326-333. Qiao, H., Y. Noda, H. Kamei, T. Nagai, H. Furukawa, H. Miura, Y. Kayukawa, T. Ohta and T. Nabeshima (2001). 'Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.' Neuroreport 12(1): 11-15. Ratra, G. S., S. G. Kamita and J. E. Casida (2001). 'Role of human GABA(A) receptor beta3 subunit in insecticide toxicity.' Toxicol Appl Pharmacol 172(3): 233-240. Redgrave, P., N. Vautrelle and J. N. Reynolds (2011). 'Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement.' Neuroscience 198: 138-151. Renju, G. L., S. Manoharan, S. Balakrishnan and N. Senthil (2007). 'Chemopreventive and antilipidperoxidative potential of Clerodendron inerme (L) Gaertn in 7,12-dimethylbenz(a)anthracene induced skin carcinogenesis in Swiss albino mice.' Pak J Biol Sci 10(9): 1465-1470. Robertson, M. M. (2003). 'Diagnosing Tourette syndrome: is it a common disorder?' J Psychosom Res 55(1): 3-6. Sacchetti, B., B. Scelfo and P. Strata (2005). 'The cerebellum: synaptic changes and fear conditioning.' Neuroscientist 11(3): 217-227. Saitow, F., M. Murano and H. Suzuki (2009). 'Modulatory effects of serotonin on GABAergic synaptic transmission and membrane properties in the deep cerebellar nuclei.' J Neurophysiol 101(3): 1361-1374. Saka, E. and A. M. Graybiel (2003). 'Pathophysiology of Tourette's syndrome: striatal pathways revisited.' Brain Dev 25 Suppl 1: S15-19. Sanz, M. J., M. L. Ferrandiz, M. Cejudo, M. C. Terencio, B. Gil, G. Bustos, A. Ubeda, R. Gunasegaran and M. J. Alcaraz (1994). 'Influence of a series of natural flavonoids on free radical generating systems and oxidative stress.' Xenobiotica 24(7): 689-699. Scahill, L., P. B. Chappell, R. A. King and J. F. Leckman (2000). 'Pharmacologic treatment of tic disorders.' Child Adolesc Psychiatr Clin N Am 9(1): 99-117. Scahill, L. D., J. F. Leckman and K. L. Marek (1995). 'Sensory phenomena in Tourette's syndrome.' Adv Neurol 65: 273-280. Schmahmann, J. D. (2004). 'Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome.' J Neuropsychiatry Clin Neurosci 16(3): 367-378. Schmahmann, J. D. and D. Caplan (2006). 'Cognition, emotion and the cerebellum.' Brain 129(Pt 2): 290-292. Schmahmann, J. D. and D. N. Pandya (1997). 'The cerebrocerebellar system.' Int Rev Neurobiol 41: 31-60. Schmahmann, J. D. and J. C. Sherman (1998). 'The cerebellar cognitive affective syndrome.' Brain 121 ( Pt 4): 561-579. Schutter, D. J. and J. van Honk (2005). 'The cerebellum on the rise in human emotion.' Cerebellum 4(4): 290-294. Schutter, D. J. and J. van Honk (2005). 'A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression.' J Psychiatry Neurosci 30(2): 91-97. Sedelis, M., R. K. Schwarting and J. P. Huston (2001). 'Behavioral phenotyping of the MPTP mouse model of Parkinson's disease.' Behav Brain Res 125(1-2): 109-125. Shapiro, E., A. K. Shapiro, G. Fulop, M. Hubbard, J. Mandeli, J. Nordlie and R. A. Phillips (1989). 'Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.' Arch Gen Psychiatry 46(8): 722-730. Short, J. L., C. Ledent, E. Borrelli, J. Drago and A. J. Lawrence (2006). 'Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice.' Neurosc | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/17281 | - |
dc.description.abstract | 我們在一則臨床案例報告發現,一位患有頑固性抽動的小女孩,發現在其服用苦藍盤汁液的萃取物1小時後,她的抽動症狀獲得有效緩解。因此,我們從苦藍盤葉的乙醇萃取物中,鑑定並分離出活性成分,為一種純化合物,KLP-1。利用在動物上模擬妥瑞氏症(Tourette syndrome)及精神病分裂症的疾病模式,我們發現KLP-1能顯著地改善由甲基安非他命(methamphetamine)及NMDA通道阻斷劑所引起的前脈衝抑制不良(PPI);而且也能改善在小鼠上慢性給予天使塵(phencyclindine)來誘導社交行為退縮的現象,為在動物上模擬精神分裂症的負向症狀模式。結合學研究還表明KLP-1在GABAA受體(GABAARs)及兒茶酚臨位甲基轉移酶(COMT)有著微莫耳濃度(μM)的親和力。先前的研究還指出,KLP-1是一個GABAARs的正向調控者,其中包括在小腦顆粒細胞中獨有表現的α6次單元(α6GABAARs)。
在這項研究中,我們進而對KLP-1 進行了全面的行為研究,影響各種行為模型小鼠的運動功能,其中包括甲基安非他命(促多巴胺釋放激素)或阿樸嗎啡(多巴胺第2受體促進劑)所引起的活動力增加現象,以及後者所誘使的刻版化攀爬行為。我們還研究了抑制COMT是否對KLP-1的效果有貢獻。要做到這一點,使用α6GABAAR的正向調控者Ro15-4513作為正向對照以及不影響α6GABAAR的diazepam作為負向對照,同時,一個非競爭α6GABAAR的拮抗劑furosemide也被使用。此外,COMT的選擇性抑制劑OR-486被用來作為COMT抑制效果的正向對照。 第一部分的動物行為模式實驗,我們發現不論是腹腔注射或小腦埋管給藥KLP-1,皆會修復甲基安非他命(促多巴胺分泌素)所造成活動力增加的現象。且小腦內注射α6GABAA接受器的活化劑Ro15-4513,也可修復甲基安非他命所造成高活動力的現象。另外,相較於KLP-1與Ro15-4513,diazepam無法作用於α6GABAAR。在小腦內注射diazepam後,並無法修復甲基安非他命所造成活動力增加的現象。另外也使用對於α6GABAA接受器有高選擇性的阻斷劑,furosemide,其可有效的抑制KLP-1與Ro15-4513所造成修復甲基安非他命活動力增加的效果。另外,我們也用了典型的COMT抑制劑OR-486,其並不對甲基安非他命所造成高活動力的現象造成影響。這些結果顯示KLP-1修復甲基安非他命所造成活動力增加的現象歸因於其在小腦顆粒細胞的α6GABAA接受器的正向調控效果,並非歸因於COMT抑制的效果。 第二部分的動物行為模式實驗,我們發現KLP-1是不對阿樸嗎啡(多巴胺第2受體促進劑)所造成活動力增加及刻板化的攀爬行為有影響。而市售的抗精神疾病藥物haloperidol,能顯著地改善阿樸嗎啡所誘導的刻板化攀爬行為。相對於KLP-1,diazepam在修復阿樸嗎啡所造成活動力增加情形的劑量下,也觀察到有嚴重的鎮靜、抗焦慮(在升高十字迷津測試下)和活動力削弱的情形。另外,在KLP-1能有效的改善甲基安非他命所誘導高活動力的劑量下,則是發現不影響自發性探索行為、肢體運動的協調性(在滾輪試驗測試下)、也不造成任何鎮靜或抗焦慮的作用。所以KLP-1的作用形式是不同於diazepam的,例如在KLP-1扮演正向調控效果及在diazepam俱敏感性GABAA受體α1-3,5次單元(被指出與抗焦慮的效果相關),結果指出對KLP-1能修復高活動力行為是不具有貢獻的。 總結,在KLP-1有效地修復由大量多巴胺所誘導活動力增加的劑量下,同時是沒有任何副作用的,例如破壞自發性探索行為、肢體運動協調性、運動力削弱或鎮靜。而其修復高活動力的現象可能藉由在小腦顆粒細胞中正向調控GABAA受體,增加小腦的調控,進而抑制紋狀體(striatal)的多巴胺系統。KLP-1的這些作用,加上其能修復前脈衝抑制不良的缺陷以及社交行為退縮的特質,顯示KLP-1很有潛力發展成治療精神分裂症及抽動症狀的藥物。特別值得一提KLP-1在改善社交行為退縮現象上,與精神分裂症病患的負向症狀是很類似的,負向症狀是現今抗精神病藥物無法有效治療,而亟待解決的臨床問題。在KLP-1進行基因毒性試驗(GLP TOX test)後,能進而支持藥物發展安全性的問題。 | zh_TW |
dc.description.abstract | In a pediatric patient with intractable motor tics, we previously found that her motor tics was subsided within 1 hour after taking the leaf extract of Clerodendron inerme (CI) Gaertn. Therefore, we have tried to identify the active constituent(s) from the ethanol extract of CI leaves and isolated a pure compound, KLP-1. In animal models mimicking Tourette syndrome (TS), a spectrum of tic disorders, and schizophrenia, we found that KLP-1 significantly rescued the disruption of prepulse inhibition (PPI) induced by methamphetamine and NMDA channel blockers, as well as improved the social withdrawal like behaviors in mice induced by chronical treatement with phencyclindine, an animal model mimicking the negative syndrome of schizophrenia. Binding studies also demonstrated KLP-1 with micromolar affinity to GABAA receptors (GABAARs) and catechol-O-methyltransferase (COMT). A previous study also demonstrated that KLP-1 is a positive modulator of GABAARs, including the subtype of α6 subunit-containing GABAARs (α6GABAARs), which is exclusively expressed in the cerebellar granule cells.
In this study, we further conducted a comprehensive study examining effects of KLP-1 on motor functions of mice by various behavioral models, including the hyperlocomotion induced by methamphetamine (a dopamine releaser) or by apomorphine (a D2 receptor agonist), and stereotypy climbing behaviors induced by apomorphine. We also examined the relative contribution of activation of α6GABAARs and COMT inhibition in the effects of KLP-1. To serve the purpose, we used Ro15-4513, a positive modulator of α6GABAAR as a positive controls, and diazepam that does not affect α6GABAAR as a negative control, and furosemide, a non-competitive α6GABAAR antagonist. Besides, OR-486, a COMT selective inhibitor, was used as a positive control for COMT inhibition. First, we found that either intraperitoneal (i.p.) or intra-cerebellar (i.cb.) microinjection of KLP-1 significantly normalized the hyperlocomotion induced by methamphetamine, a dopamine releaser. Ro15-4513 given by i.cb. microinjection also effectively normalized methamphetamine-induced hyperlocomotion. However, i.cb. diazepam, which is insensitive to α6GABAAR, did not affect methamphetamine-induced hyperlocomotion. Moreover, i.cb. furosemide, which selectively antagonizes α6GABAARs, significantly antagonized the normalizing effect induced by i.cb. KLP-1 and Ro15-4513 on methamphetamine-induced hyperlocomotion. On the other hand, OR-486, a typical COMT inhibitor, did not affect methamphetamine-induced hyperlocomotion. These results suggest that the inhibitory effect of KLP-1 on methamphetamine-induced hyperlocomotion is mediated by positively modulating α6GABAARs in cerebellar granule cells, but not by COMT inhibition. Second, we found that KLP-1 (i.p.) did not affect hyperlocomotion and stereotypy climbing behaviors induced by apomorphine, a D2 receptor agonist. Haloperidol, a commercially available antipsychotic, significantly reduced apomorphine-induced stereotypy climbing behaviors. Unlike KLP-1, diazepam reduced apomorphine-induced hyperlocomotion. This effect was observed at doses of diazepam with severe sedative, anxiolytic (revealed by the elevated plus maze test) and motor weakness activity. In contrast, KLP-1 at doses effectively normalized methamphetamine-induced hyperolocomotion did not affect spontaneous motor activity and motor coordination in the rotarod test, but did not display any significant sedation or anxiolytic activity. Therefore, the action mode of KLP-1 is different from that of diazepam, i.e. the positive modulatory effect of KLP-1 on diazepam-sensitive GABAARs, the α1-3,5 subunit-containing GABAARs, dose not contribute to KLP-1-induced normalization of hyperlocomotion. In summary, KLP-1 at the doses effectively normalizing hyperlocomotion induced by hyper-dopaminergic tone did not have side effects, such as impairment of spontaneous motor activity, motor coordination, causing motor weakeness or sedation. Its reduction of hyperlocomotion might be attributed to a positive modulation of GABAARs in cerebellar granule cells, leading to enhancing cerebellar inhibitory control on the striatal dopaminergic activity. In combination with its effectiveness in rescuing PPI disruptions and in improving social withdrawal behaviors, KLP-1 is a potential compound for treating schizophrenia or tic disorders. Characteristically, KLP-1-induced improvement of social withdrwal behaviors, which resembles the negative syndrome of schizophrenia patients, is especially noteworthy since schizophrenia negative syndrome is resistant to current antipsychotic drugs and is an unmet medical need in clinical practice. The absence of genotoxicity of KLP-1 in a GLP TOX test further supports its safety issue in terms of drug development. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T00:04:44Z (GMT). No. of bitstreams: 1 ntu-102-R00443003-1.pdf: 2215833 bytes, checksum: 9b4023d230ee155901000a86d8e90c22 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 口試委員會審定書 i
Acknowledgement (誌謝) ii Abbreviation (縮寫表) iv Abstract in Chinese (中文摘要) vi Abstract in English (英文摘要) viii Introduction 1. Preface 1 2. Background 4 3. KLP-1 isolated from Clerodendron inerme (L.) Gaertn (CI) 10 4. Cerebellum 13 5. GABAA receptor (GABAAR) 17 Aim 20 Materials and Methods 22 Results 1. Effects of KLP-1 on methamphetamine-induced hyperlocomotor activity 30 2. Apomorphine-induced hyperlocomotion and stereotypy climbing behaviors as a mouse model of TS and schizophrenia 37 3. Effects of KLP-1 on anxiety test 42 4. Rotarod performance of KLP-1 44 5. Sedation assessment of KLP-1 45 Discussion 47 Conclusion 67 References 68 Tables 92 Figures 96 | |
dc.language.iso | en | |
dc.title | 苦藍盤萃取物在神經/精神疾病動物模式之行為研究 | zh_TW |
dc.title | Behavioral studies of KLP-1 in animal models of neurological and psychiatric disorders | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳景宗(Jin-Chung Chen),黃偉展(Wei-Jan Huang),李立仁(Li-Jen LEE),黃玲玲(Ling-Ling Hwang) | |
dc.subject.keyword | 苦藍盤,高活動力,刻版化攀爬行為,動物模式,小腦,妥瑞氏症,精神分裂症, | zh_TW |
dc.subject.keyword | KLP-1,hyperlocomotion,stereotypy climbing,cerebellum,tourette syndrome,schizophrenia, | en |
dc.relation.page | 117 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2013-08-14 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2.16 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。